Major UK trial to assess whether cannabis-based drug could extend life for thousands with aggressive brain tumours
A major UK trial of cannabis-based drug Sativex in treating the most aggressive form of brain tumour is to launch at 15 NHS hospitals, following promising results from a phase I study in 27 patients.
Developments in cannabis-based drug trial for glioblastomas
The Brain Tumour Charity responds to trial suggesting cannabis-based drug could be combined with chemotherapy in recurrent glioblastomas
NICE publish disappointing draft guidance on cannabis-based medicinal products
The National Institute for Health and Care Excellence (NICE) published draft recommendations regarding the use of cannabis-based medicinal products in England on 8 August 2019 which are unfortunately disappointing.
Patients struggling to access cannabis-based medicine via prescription, report finds
A report published today into the use of medicinal cannabis for problems such as nausea caused by chemotherapy says patients have had their expectations raised unfairly by a change in the law last year
New guidance for prescription of medicinal cannabis but access is limited
Yesterday, new guidance has been provided to clinicians by NHS England for the prescription of medicinal cannabis but access to the drug remains highly restricted
Cannabis-based medicinal products available by special prescription by 1 November
Yesterday the Home Secretary, Sajid Javid MP, announced cannabis-based medicinal products will be available through special prescription by 1 November to patients in England, Wales, Scotland and Northern Ireland
Cannabis oil – A patient’s right to choose
Last week, Billy Caldwell, a severely epileptic twelve year old boy, had his cannabis oil confiscated at Heathrow airport
UK research into the use of cannabidiol to treat brain tumours
Researchers from the Nottingham University’s children’s brain tumour centre are now looking into the effects of cannabidiol (CBD), the non-psychoactive ingredient in marijuana
Cannabis-derived medication shows promise in Phase 2 clinical study
Earlier this week, positive results were released from a clinical study testing a combination of tetrahydrocannabinol (THC) and cannabidiol (CBD) as a treatment in recurrent glioblastoma (GBM) patients in the UK.